Pharmaceutical Safety Review • Moderate Interaction Classification

Fisetin vs Quercetin Phytosome Prescription Drug Interactions & CYP450 Profile

Systematic analysis of cytochrome P450 enzyme metabolism, renal clearance competition, and clinical contraindications.

Absolute Clinical Contraindications

  • Active chemotherapy or radiation (may interfere with pro-apoptotic oncology drugs)
  • Bleeding disorders or anticoagulant medications
  • Renal impairment

Reported Clinical Adverse Events

  • Mild transient headache during pulse dosing
  • Flushing
  • Occasional mild dyspepsia

Hepatic Cytochrome P450 (CYP) & Transporter Pathways

Compounds that modulate CYP3A4, CYP2D6, or P-glycoprotein (P-gp) can alter the bioavailability of concurrent medications including statins, anticoagulants, immunosuppressants, and blood pressure therapies:

  • CYP3A4 Substrate / Inhibitor: Potential competition with oral medications metabolized through hepatic CYP3A4 pathways.
  • Gastrointestinal Transit Modulation: GLP-1 receptor agonists and delayed-release botanicals slow gastric emptying, which may delay Tmax for orally administered therapeutics.
  • Pharmacokinetic Half-Life Clearance: Systemic clearance requires approximately 5 elimination half-lives (Fisetin: 3-4 hours; Quercetin: 11-28 hours).

Protocol Audit Links for Fisetin vs Quercetin Phytosome

← Return to Fisetin vs Quercetin Phytosome Monograph Calculate Weight Dosage Table → Launch Full Multi-Drug Interaction Checker →